Previous Page  4 / 15 Next Page
Information
Show Menu
Previous Page 4 / 15 Next Page
Page Background

Page 37

Notes:

conferenceseries

.com

Volume 7, Issue 1 (Suppl)

J Clin Exp Pathol

ISSN: 2161-0681 JCEP, an open access journal

Pediatric Pathology & Laboratory Medicine 2017

March 15-16, 2017

March 15-16, 2017 London, UK

12

th

International Conference on

Pediatric Pathology & Laboratory Medicine

Evaluation of human epidermal growth factor receptor (HER-2/

neu

) in gastric adenocarcinoma: A study

from South Asia region

Asma Shabbir, Muhammad Asif Qureshi, Talat Mirza

and

Abdullah Bin Khalid

Jinnah Sindh Medical University, Pakistan

Background & Aim:

Gastric cancer is the third leading cause of cancer mortality worldwide. Human epidermal growth factor (HER-

2

/neu

) has shown strong therapeutic implication in breast cancer. Expression of HER-2

/neu

in gastric cancer has been reported from

across the world, it is still unknown from South Asia region. The aim of this study is to evaluate HER-2

/neu

expression in gastric

adenocarcinomas and to correlate with various clinicopathological variables.

Patients & Method:

A total of 95 consecutive patients undergoing endoscopic biopsy or gastrectomy were recruited in this study

after institutional ethical approval. Clinicopathological parameters of all patients were recorded and hematoxylin and eosin (H&E)

staining was performed. Expression of HER-2

/neu

was investigated by immunohistochemistry using α-HER-2 antibody. Hofmann

validation scoring system was used and its association was seen with various clinicopathological variables including age, gender,

histopathological type, grade and stage of the tumor.

Results:

HER-2

/neu

over expression was found in 21 (22.1%) cases from the total of 95 gastric adenocarcinomas. HER-2

/neu

was

significantly expressed in low grade gastric cancer (p=0.030). Although there was no significant difference between HER-2

/neu

expression and other variables, HER-2

/neu

score 3+ was higher in females, age >60 years, Laurens intestinal type and IIIC stage.

Conclusion:

HER-2

/neu

is expressed in a limited group of gastric cancer patients in Pakistani population. Our findings indicate a

significant strong association of HER-2

/neu

expression with low grades of gastric cancer.

Biography

Asma Shabbir has done her MBBS from B J Medical College, Pune, India. She has done her Post-graduation from Dow International Medical College, Karachi,

Pakistan. She has a passion towards research and concerned for better prognosis of the patient. She has presented her research work in many conferences.

Recently, she received the Young Researcher Award at the International Conference of Digestive Diseases in Dubai 2016. She is a member of different scientific

and research associations. At present, she is working as a Researcher and as an Assistant Professor in the Department of Pathology, Jinnah Sindh Medical

University, Pakistan.

drasma52@gmail.com

Asma Shabbir et al., J Clin Exp Pathol 2017, 7:1 (Suppl)

http://dx.doi.org/10.4172/2161-0681.C1.031